TR
Rhelion Life Sciences Corp.
TRUFF · OTC
$0.03 +19.81% (+$0.00)
1M +25.74%
Market Cap $14.7M
P/E Ratio -
Div. Yield -
ROE 43.00%
Piotroski F-Score Weak
2/9Valuation
68 /100
Cheap P/S 4.77x
P/B 0.78x
P/E N/A
Growth
23 /100
Declining Rev. growth 2.03%
Book val. growth 22.86%
EPS growth N/A
Profitability
14 /100
Weak Gross margin 36.80%
Net margin 213.37%
Op. margin 263.74%
Quality
2 /100
Poor ROIC 42.04%
ROE 43.00%
ROA 30.04%
Debt
69 /100
Low Debt/Equity 0.02x
Current ratio 3.25x
Int. coverage -97.77x
Stability
47 /100
Moderate Beta 0.96x
Rev. volatility 17.75%
EPS volatility 67.06%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TRUFF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Todd Michael Shapiro
Employees
104
Headquarters
Toronto
Prihajajoči dogodki
30 NOV.
Earnings
Upcoming earnings report